Cargando…

Prospective Clinical Trials to Advance the Study of Immune Checkpoint Inhibitor Toxicity

Immune checkpoint inhibitors (ICIs) are a class of drug that produces durable and sustained anti-tumour responses in a wide variety of malignancies. The exponential rise in their use has been mirrored by a rise in immune-related adverse events (IrAEs). Knowledge of such toxicities, as well as effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Cluxton, Christopher, Naidoo, Jarushka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378048/
https://www.ncbi.nlm.nih.gov/pubmed/37504362
http://dx.doi.org/10.3390/curroncol30070502